Nordic presence in Portugal

AstraZeneca

Pharmaceuticals (Lisbon)

AstraZeneca – Produtos Farmacêuticos, Lda (NIF 502942240), formerly Astra Portuguesa, is the Portuguese company of AstraZeneca, the Anglo-Swedish group formed in 1999 when Sweden’s Astra AB, founded in Södertälje in 1913, merged with Britain’s Zeneca. On 1 April 2026 it opened a new head office in Lisbon’s Parque das Nações after more than 25 years in Barcarena (Oeiras); the district also hosts the global services hub AstraZeneca launched in 2024, for which it has set out €600 million of combined investment over 2024–2033. The company employed about 579 people in Portugal in 2025 and aimed for 750 by the end of the first quarter of 2026.

Group headquartersCambridge, UK (Cambridge Biomedical Campus); primary listing in London, secondary listings on Nasdaq Stockholm and the New York Stock Exchange
Founded6 April 1999, by the merger of Sweden’s Astra AB (founded 1913 in Södertälje) and the UK’s Zeneca Group; Astra shareholders received 46.5% of the combined company
Employees (group)96,100 (Annual Report 2025); the Gothenburg (Mölndal) site in Sweden, one of the group’s strategic R&D centres, has more than 2,600
Portuguese entityAstraZeneca – Produtos Farmacêuticos, Lda — NIF 502942240 — Avenida Dom João II, n.º 13, 1990-077 Lisboa; formerly Astra Portuguesa – Produtos Farmacêuticos, Lda; share capital €1.5 million; CAE 46460 (wholesale of pharmaceutical products)
Employees (Portugal)About 579 in 2025, with a target of 750 by the end of the first quarter of 2026 (AICEP)
Lisbon hubGlobal services hub launched in 2024, in Parque das Nações: project management and process analytics, contracting and legal, HR services and procurement; €600 million combined investment planned for 2024–2033
ManagementNathalie Cardinal von Widdern, President of AstraZeneca Portugal
DirectionSweden / UK → Portugal

Corridor footprint

AstraZeneca’s Portuguese operating company is AstraZeneca – Produtos Farmacêuticos, Lda (NIF 502942240), a private limited company with share capital of €1.5 million. Its registered object covers the production, import, export, storage and wholesale distribution of medical devices and, more generally, the marketing of pharmaceutical products and diagnostics; its main activity code is CAE 46460, wholesale of pharmaceutical products. The business register records its former name as Astra Portuguesa – Produtos Farmacêuticos, Lda, a link back to Sweden’s Astra AB, which some 400 doctors and apothecaries founded in Södertälje in 1913 and which was Sweden’s largest pharmaceutical company when it merged with Zeneca in 1999. For more than 25 years the Portuguese company worked from offices in Barcarena, in the municipality of Oeiras. After the move to Lisbon, that building — about 4,300 m² of gross construction area on a plot of some 13,000 m² — was sold to Oeiras International School, with the property consultancy Dils advising on the sale.

The new head office, at Avenida Dom João II, 13, in Parque das Nações, was inaugurated on 1 April 2026. According to AstraZeneca Portugal, the event was opened by Health Minister Ana Paula Martins and closed by Finance Minister Joaquim Miranda Sarmento, with a panel on the importance of the life sciences for growth and innovation made up of Nathalie Cardinal von Widdern, President of AstraZeneca Portugal; Ruud Dobber, executive vice-president of the group’s BioPharmaceuticals business unit; former foreign minister Paulo Portas; and Lisbon mayor Carlos Moedas. The company says it invests in Portugal both through its local subsidiary and through a global services hub, launched in 2024, that serves AstraZeneca worldwide from Lisbon. Presenting the hub project to AICEP, Portugal’s trade and investment agency, in 2025, AstraZeneca put the combined investment for 2024–2033 at €600 million, of which about €60 million had already been invested, and listed the hub’s functions as project management and process analytics, contracting and legal, HR services and procurement. At that point it employed about 579 people in Portugal and expected to reach 750 by the end of the first quarter of 2026.

Why this matters for the corridor

AstraZeneca shows a Swedish-rooted multinational using Portugal for more than medicine sales. Its Portuguese company carries the Astra name in its corporate history; the group’s Swedish base remains large, with Gothenburg (Mölndal) one of its strategic R&D centres and home to its largest unit for manufacturing clinical supplies; and Lisbon now runs services for the whole group. The company is also tying itself into the city’s health-innovation scene: it is a founding partner, with the European Longevity Hub, CUF, Linde and SITIO, of the Healthhub that Unicorn Factory Lisboa presented at the end of 2025, a space for health start-ups in the SITIO building on Rossio.

Recent activity

10 July 2026 — AstraZeneca Portugal sets out its role as a founding partner of the Unicorn Factory Lisboa Healthhub, which offers 11 private rooms and 56 workstations to start-ups and teams.

22 April 2026 — The former Barcarena offices are reported sold to Oeiras International School, which plans to open a campus there for the senior years of its programme in the next academic year.

1 April 2026 — New Portuguese head office opens in Parque das Nações, Lisbon.

Sources: nif.pt and racius.com (NIF 502942240); astrazeneca.pt (contacts page; news items of 26 June and 10 July 2026); AICEP / Portugal Global (“AstraZeneca vai investir em novo centro de competências” and “AstraZeneca invests €600 million in new hub in Lisbon”, 2025); Essential Business (22 April 2026); astrazeneca.com (company overview and Gothenburg site pages); Wikipedia (AstraZeneca; Astra AB). Spotted an error? Email miguel@fractio.se.

Status: Compiled from public sources · Last verified: · Update this profile

Update this profile

Work at AstraZeneca? Send corrections or additions. Every update is checked before it is published; submissions are reviewed within a few working days.

Thinking about entering Portugal?

Fractio helps Nordic companies enter the Portuguese market — from market sizing to first sales, hiring, and legal setup.

Talk to Fractio →